Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

Studies with human growth hormone (HGH): An attempt to

Skip to main contentSkip to article Access through your organization Purchase PDF Patient Access Abstract All fifteen patients (twelve hypopituitary dwarfs, one primordial dwarf and two patients with gonadal dysgenesis) studied exhibited one or another metabolic response to human growth hormone (HGH) during initial short-term studies. Decreased urinary nitrogen, increased urinary calcium and increased urinary hydroxyproline: creatinine ratio were observed in all patients so studied. All twelve hypopituitary dwarfs showed a significant fall in serum urea nitrogen. The magnitude of the various responses to HGH varied in individual patients. No effect of the short-term administration of HGH could be used to predict the response in linear growth to prolonged therapy with the possible exception of minimal nitrogen retention (< 1.0 gm. per day). The data presented here suggest that the administration of HGH, 5 mg. daily for six days, will correct reactive hypoglycemia but that a longer perio

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Skip to main contentSkip to article

Access through your organization Purchase PDF Patient Access

Abstract

All fifteen patients (twelve hypopituitary dwarfs, one primordial dwarf and two patients with gonadal dysgenesis) studied exhibited one or another metabolic response to human growth hormone (HGH) during initial short-term studies. Decreased urinary nitrogen, increased urinary calcium and increased urinary hydroxyproline: creatinine ratio were observed in all patients so studied. All twelve hypopituitary dwarfs showed a significant fall in serum urea nitrogen. The magnitude of the various responses to HGH varied in individual patients. No effect of the short-term administration of HGH could be used to predict the response in linear growth to prolonged therapy with the possible exception of minimal nitrogen retention (< 1.0 gm. per day).

The data presented here suggest that the administration of HGH, 5 mg. daily for six days, will correct reactive hypoglycemia but that a longer period of treatment is necessary for correction of sensitivity to exogenous insulin.

No increase in growth rate was observed in the primordial dwarf treated for six months with Wilhelmi HGH, (W HGH), 2 mg. daily for the first fourteen days of each twenty-eight day cycle. Two patients with gonadal dysgenesis treated in a similar manner with 5 mg. of HGH daily showed accelerated linear growth.

All preparations of HGH used were metabolically active, including two preparations from pituitaries from embalmed bodies. All three of the preparations of HGH, including one from pituitaries from embalmed bodies, used for prolonged treatment were capable of stimulating growth rate. A comparison of the potency of the various preparations is not possible due to the limited use of any HGH other than that extracted by Wilhelmi.

During initial metabolic studies the administration of HGH was equally effective when the total dosage was given in one dose daily or in divided doses.

No unequivocal evidence for contamination of the HGH with TSH, ACTH or gonadotropins was obtained.

Ten of twelve hypopituitary dwarfs showed accelerated growth when given 2 mg. of HGH daily for the first fourteen of each twenty-eight days. One patient failed to respond at this dosage level but showed comparable response to a dose of 5 mg. HGH.

Patients receiving more than one eight-month course of injections of HGH, using the same dosage and preparation, exhibited diminished growth response during succeeding courses. This waning effectiveness occurred in one patient despite increases in the dose.

Access through your organization

Check access to the full text by signing in through your organization.Access through your organization

References (74)

Endocrine problems in adolescence

J. Pediat.

(1941) C.W. Charny et al.

Development of the testis. A histologic study from birth to maturity with some notes on abnormal variations

Fertility & Sterility

(1952) J.A. Brasel et al.

Evaluation of seventy-five patients with hypopituitarism beginning in childhood

Am. J. Med.

(1965) W.R. Campbell et al.

The determination of nitrogen by modified Kjeldahl method

J. Biol. Chem.

(1937) E.P. Clark et al.

A study of the Tisdall method for the determination of blood serum calcium with a suggested modification

J. Biol. Chem.

(1925) C.H. Fiske et al.

The Colorimetric determination of phosphorus

J. Biol. Chem.

(1925) A. Bodansky

Phosphatase studies. II. Determination of serum phosphatase. Factors influencing the accuracy of the determination

J. Biol. Chem.

(1933) J.A. Trafford et al.

Human growth hormone in pituitary infantilism

Lancet

(1963) H. Gershberg et al.

Long term treatment of hypopituitary and of achondroplastic dwarfism with human growth hormone

Metabolism

(1964) J.C. Beck et al.

Metabolic effects of human and monkey growth hormone in man

Science

(1957) J.C. Beck et al.

Metabolic effects of human and monkey growth hormone in man

Ann. Int. Med.

(1958) D. Ikkos et al.

The effect of human growth hormone in man

Acta Endocrinol.

(1959) P.H. Henneman et al.

Effects of human growth hormone in man

J. Clin. Invest.

(1960) British Medical Research Council

The effectiveness in man of human growth hormone

Lancet

(1959) J.J. Hutchings et al.

Metabolic changes produced by human growth hormone (Li) in a pituitary dwarf

J. Clin. Endocrinol.

(1959) D.M. Bergenstal et al.

The metabolic effects of human growth hormone and growth hormone of other species in man

J. Clin. Endocrinol.

(1960) T.H. Shepherd et al.

Human growth hormone. I. Metabolic balance studies carried out in hypopituitary child

J. Dis. Child.

(1960) H. Gershberg

Metabolic and renotropic effects of human growth hormone in disease

J. Clin. Endocrinol.

(1960) A.P. Forbes et al.

Studies on growth arrest in gonadal dysgenesis: response to exogenous human growth hormone

Metabolism

(1962) T.H. Shepherd et al.

Human growth hormone. II. Further study of its effect on growth in dwarfism

J. Pediat.

(1960) R.F. Escamilla et al.

Long-term effects of HGH (Li) in a pituitary dwarf

J. Clin. Endocrinol.

(1961) W.H. Daughaday et al.

Sulfation factor measurement as an aid in the recognition of pituitary dwarfism

J. Clin. Endocrinol.

(1963) N.H. Callow et al.

Colorimetric determination of substance containing the grouping —CH2CO—in urine extracts as indication of androgen content

Biochem. J.

(1938) C.C. Jensen

Quantitative determination of dehydroisoandrosterone. II. Determination of urinary extracts

Acta Endocrinol.

(1950) E.M. Glenn et al.

Chemical method for the determination of 17-hydroxycorticosteroids and 17-ketosteroids in urine following hydrolysis with β-glucuronidase

J. Clin. Endocrinol.

(1953) F.M. Kenny et al.

Cortisol production in newborn and older children

Pediatrics

(1963) W. Hung et al.

Medical therapy of thyrotoxicosis in children

Pediatrics

(1962) E. Shorr

A new technique for staining vaginal smears. III. A single differential stain

Science

(1941) W.D. Nelson

Interpretation of testicular biopsy

J.A.M.A.

(1953) N.F. Klinefelter et al.

Experience with a quantitative test for normal or decreased amounts of follicle stimulating hormone in the urine in endocrinological diagnosis

J. Clin. Endocrinol.

(1943) J.T. Bradbury et al.

Adsorption of urinary gonadotropins on kaolin W.H. Daughaday et al.

Sulfation factor activity of sera from patients with pituitary disorders

J. Clin. Endocrinol.

(1959) J.E. Howard et al.

Studies on fracture convalescence. II. The influence of diet on post-traumatic nitrogen deficit exhibited by fracture patients

Bull. Johns Hopkins Hosp.

(1944) C.F. Consolazio et al.

Metabolic Methods: Clinical Procedures in The Study of Metabolic Function

(1951) D.J. Prokop et al.

A specific method for the analysis of hydroxyproline in tissues and urine

Anal. Biochem.

(1960) V.P. Dole

The relation between non-esterified fatty acids in plasma and the metabolism of glucose

J. Clin. Invest.

(1956)

☆

This work was supported by Grant A-4499 and A-180. Drs. Wright, Brasel, Aceto, Finkelstein, Kenny and Spaulding were supported by Trainee Grant No. 2A-5219, U. S. Public Health Service.

1

From The Department of Pediatrics, Johns Hopkins School of Medicine and Hospital, Baltimore, Maryland.

†

Present address: Illinois State Pediatric Institute, 1640 W. Roosevelt Road, Chicago, Illinois.

‡

Present address: Children's Hospital, 219 Bryant Street, Buffalo, New York

§

Present address: Department of Pediatrics, Montefiore Hospital, Bronx, New York.

∥

Present address: Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.

Present address: Department of Pediatrics, University of Kansas Medical Center, Kansas City, Kansas.View full text

Copyright © 1965 Published by Excerpta Medica Inc.

Connected topics

Follow this recovery question